Contract Services

Samsung Biologics to build Plant 5 for Bio Campus II expansion.

The company plans to begin construction in the first half of 2023 and commence operations in 2025 As part of Samsung Biologics' second Bio Campus, ...

 March 17, 2023 | News

Mabwell begins first human trial of iron-regulating drug 9MW3011

The study (CTR20230046) is a phase 1, single center, randomized, double-blind,placebo-controlled, ascending dose study to evaluate the safety, ...

 March 15, 2023 | News

Antengene's ATG-022 Phase I CLINCH Trial for Solid Tumor Treatment Receives IND Approval in China

-  Discovered and developed in-house by Antengene's R&D team, ATG-022 is an antibody-drug-conjugate (ADC) targeting the Tumor Assoc...

 March 14, 2023 | News

H1 Launches Advanced Diversity Insights and Clinical Trial Performance Insights

H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced the availability of indication-level ...

 March 13, 2023 | News

Boan Biotech Completes Patient Enrollment for Aflibercept Trial in China

Aflibercept is a homodimeric fusion protein consisting of portions of human vascular endothelial growth factor receptor (VEGFR) extracellular domains (VEGF...

 March 13, 2023 | News

Vetter strengthens worldwide commitment to sustainable business practices

Globally, Vetter is one of over 300 companies in the pharma and biotech industrythat have signed the UN Global Compact Membership drives expansion of ec...

 March 08, 2023 | News

Study finds plate choice can affect EM microbial air sampling accuracy and Annex 1 compliance

 Cherwell, specialists in cleanroom microbiology solutions for the pharmaceutical, healthcare and related industries, has published the findings of an...

 March 07, 2023 | News

GenScript ProBio Congratulates Eutilex's IND Clearance from MFDS

GenScript ProBio extends congratulations on this. 2 years ago, GenScript ProBio and Eutilex announced that the parties entered into strategic collaboration...

 March 07, 2023 | News

AtomVie Global Radiopharma builds industry-leading CDMO facility in Ontario.

Currently located on the McMaster University campus, AtomVie successfully operates a global leading Contract Development and Manufacturing Organi...

 March 02, 2023 | News

Thermo Fisher Scientific’s Clinical Research Business Recognized by ISG for Digital Services Leadership

In its 2022 ISG Provider Lens™ Life Sciences Digital Services Global Report, ISG recognized Thermo Fisher’s clinical research business for...

 February 27, 2023 | News

Porton Advanced and Yinjia Biosciences Partner to Enhance CDMO Technology Platform

Porton Advanced CDMO offers end-to-end gene and cell therapy services covering plasmids, cell therapy, gene therapy, oncolytic virus, mRNA therapy, and bac...

 February 27, 2023 | News

GenScript ProBio and RVAC Medicines Partner for COVID-19 Vaccine Plasmid DNA Manufacturing

GenScript ProBio will provide GMP plasmid manufacturing service for RVAC Medicines' program, RVM-V001. This partnership will enable to accelerate its clini...

 February 23, 2023 | News

Thermo Fisher Scientific Selected to Support National Institute of Health’s Blueprint MedTech program

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been awarded a five-year contract to provide ...

 February 21, 2023 | News

EmVenio prioritizes inclusion in clinical research with new patient-centric model

In an effort to maximize diversity, equity and inclusion in clinical research, EmVenio Research activated 10 community research sites among diver...

 February 18, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close